michigan glp-1 vomiting lawyer Ozempic Patients claim blindness, bowel injuries

It is approved for: (1) chronic weight management in adults living with obesity or who are overweight with at least one comorbid condition, and (2) to reduce the risk of MACE in adults with overweight or obesity and established CVD

We source research from peer-reviewed medical journals, top government agencies, leading academic institutions, and respected advocacy groups

Inject subcutaneously at a 90-degree angle, holding the pen in place for the recommended duration (varies by product, typically 610 seconds) to ensure full dose delivery

If you fall in this category: we're sorry

The same mechanisms that make GLP-1 drugs effective, however, also carry the potential for serious health risks

Available from: Tschope C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kuhl U, Kandolf R, Schultheiss HP